News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Roger A. Goldberg, MD, MBA

Advertisement

Bay Area Retina Associates in Walnut Creek, California

Articles by Roger A. Goldberg, MD, MBA

Q&A: Roger A. Goldberg on the 48-Month results from OAKS, DERBY, and GALE open-label extension

ByRoger A. Goldberg, MD, MBA,Martin David Harp,Sydney M Crago
August 14th 2025
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Modern Retina

    1

    CONDOR clinical trial: Brolucizumab superior to panretinal photocoagulation for proliferative diabetic retinopathy

    2

    Belite Bio initiates rolling NDA submission for tinlarebant in Stargardt disease type 1

    3

    Additional SOL-1 analyses show delayed CSFT worsening with AXPAXLI

    • About
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us